Search Results 411-420 of 14100 for SC

  1. Brett H. Keeling, M.D. - Doctors and Medical Staff - Mayo Clinic

    Education ; 2018. Fellowship - DermatopathologyMedical University of South Carolina ; 2017. Chief Resident - DermatologyDell Medical School at the University of ...

  2. Publications - Kostas J. Economopoulos, M.D. - Mayo Clinic

    Clark SC, Hanson JA, Lee DR, Spinner RJ, Economopoulos KJ, Hevesi M, Krych ... SC, Economopoulos KJ. Anterior Cruciate Ligament Reconstruction Using ...

  3. A Study Of Lebrikizumab In Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Participants will be randomized to receive either lebrikizumab or placebo subcutaneously (SC) every 4 weeks. Participation eligibility. Participant ...

  4. Publications - Nicholas L. Deep, M.D. - Mayo Clinic

    ... SC, Lindquist NR, Perkins EL, Tan D, Lane JI, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, West NC, Caye-Thomasen P ...

  5. Publications - Luke S. Spencer Gardner, M.D. - Mayo Clinic

    Rudisill SS, Clark SC, Nagelli CV, Spencer-Gardner LS, Couch CG, Murthy NS, Taunton MJ, Hevesi M. Outcomes of Direct Anterior Total Hip Arthroplasty in ...

  6. Publications - Chirag R. Patel, M.D. - Mayo Clinic

    Cheng J, Rolak SC, Umar SB, Zhou J, Craig FE, Kelemen K, Patel CR. Flow cytometric detection of clonal T-cell populations in CAR T-cell therapy related ...

  7. Publications - Lisa A. McGee, M.D. - Mayo Clinic

    ... SC, Gamez ME, Rwigema JM, Holtzman AL, Price DL, Janus JR, Kasperbauer JL ... SC, Gamez ME, Routman DM, Beltran CJ, Liang X. Impact of Relative ...

  8. Urology - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  9. Publications - Jessica Wilson, M.D., Ph.D. - Mayo Clinic

    ... SC, Wilson J, Rwigema JM, Chintakuntlawar AV, Mohammadi H, Holtzman AL, Price DL, Janus JR, Garcia JJ, Foote RL, Tasche KK, Ma DJ, Van Abel KM, Yin LX ...

  10. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Vaccine Therapy Plus Pembrolizumab in Treating ...